Home » Newsletters » BioWorld Asia

BioWorld Asia

April 5, 2000

View Archived Issues

MediGene, Schering Align In $52M Deal For HPV Vaccine

Researchers Identify Peptide That Triggers Celiac Disease

Celltech Buys U.S.-Based Cistron, Gains Access To IL-1 Technology

November AG Taking Program Public On Market In Germany

SR Pharma Sees Additional Positive Data From SRL172

Mologen Starts Phase II/III Cancer Gene Therapy Trial

Israeli Researchers Show Toxic Shock Antidote Works In Mice

Australian Stocks Doing Well, But Lag Behind U.S. Counterparts

Peptide Therapeutics In Talks With Potential Company Buyer

Transghne Obtains U.S. Patent Covering Adenovirus Technique

DevCo Licenses Lexipafant, Marking Third Deal In A Month

Cambridge Antibody Raises #90M In Scaled-Back Offering

Teva To Market Bio-Tropin As Part Of $20M BTG Deal

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...